Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.

Suzuki S, Nishijima T, Kawasaki Y, Kurosawa T, Mutoh Y, Kikuchi Y, Gatanaga H, Oka S.

AIDS Patient Care STDS. 2017 Mar;31(3):105-112. doi: 10.1089/apc.2016.0286.

2.

The serum heart-type fatty acid-binding protein (HFABP) levels can be used to detect the presence of acute kidney injury on admission in patients admitted to the non-surgical intensive care unit.

Shirakabe A, Kobayashi N, Hata N, Shinada T, Tomita K, Tsurumi M, Okazaki H, Matsushita M, Yamamoto Y, Yokoyama S, Asai K, Shimizu W.

BMC Cardiovasc Disord. 2016 Sep 5;16(1):174. doi: 10.1186/s12872-016-0340-1.

3.

Association between Serum Bilirubin and Estimated Glomerular Filtration Rate among Diabetic Patients.

Katoh T, Kawamoto R, Kohara K, Miki T.

Int Sch Res Notices. 2015 Jan 26;2015:480418. doi: 10.1155/2015/480418. eCollection 2015.

4.

Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes.

Kajiwara A, Kita A, Saruwatari J, Miyazaki H, Kawata Y, Morita K, Oniki K, Yoshida A, Jinnouchi H, Nakagawa K.

J Diabetes Res. 2016;2016:4626382. doi: 10.1155/2016/4626382. Epub 2016 May 9.

6.

Comparison between urine albumin-to-creatinine ratio and urine protein dipstick testing for prevalence and ability to predict the risk for chronic kidney disease in the general population (Iwate-KENCO study): a prospective community-based cohort study.

Koeda Y, Tanaka F, Segawa T, Ohta M, Ohsawa M, Tanno K, Makita S, Ishibashi Y, Itai K, Omama S, Onoda T, Sakata K, Ogasawara K, Okayama A, Nakamura M.

BMC Nephrol. 2016 May 12;17(1):46. doi: 10.1186/s12882-016-0261-3.

7.

Nighttime BP in Elderly Individuals with Prediabetes/Diabetes with and without CKD: The HEIJO-KYO Study.

Obayashi K, Saeki K, Kurumatani N.

Clin J Am Soc Nephrol. 2016 May 6;11(5):867-74. doi: 10.2215/CJN.07700715. Epub 2016 Feb 25.

8.

Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial.

Torres VE, Higashihara E, Devuyst O, Chapman AB, Gansevoort RT, Grantham JJ, Perrone RD, Ouyang J, Blais JD, Czerwiec FS; TEMPO 3:4 Trial Investigators.

Clin J Am Soc Nephrol. 2016 May 6;11(5):803-11. doi: 10.2215/CJN.06300615. Epub 2016 Feb 23.

9.

Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.

Mise K, Hoshino J, Ueno T, Hazue R, Hasegawa J, Sekine A, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Hara S, Ohashi K, Takaichi K, Ubara Y.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):593-601. doi: 10.2215/CJN.04980515. Epub 2016 Jan 22.

10.

Validity of new methods to evaluate renal function in cancer patients treated with cisplatin.

Funakoshi Y, Fujiwara Y, Kiyota N, Mukohara T, Shimada T, Toyoda M, Imamura Y, Chayahara N, Tomioka H, Umezu M, Otsuki N, Nibu K, Minami H.

Cancer Chemother Pharmacol. 2016 Feb;77(2):281-8. doi: 10.1007/s00280-016-2966-1. Epub 2016 Jan 20.

11.

CYP3A5 polymorphism affects the increase in CYP3A activity after living kidney transplantation in patients with end stage renal disease.

Suzuki Y, Fujioka T, Sato F, Matsumoto K, Muraya N, Tanaka R, Sato Y, Ohno K, Mimata H, Kishino S, Itoh H.

Br J Clin Pharmacol. 2015 Dec;80(6):1421-8. doi: 10.1111/bcp.12733. Epub 2015 Oct 3.

12.

Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic Study.

Nishijima T, Hayashida T, Kurosawa T, Tanaka N, Oka S, Gatanaga H.

PLoS One. 2015 Nov 4;10(11):e0141931. doi: 10.1371/journal.pone.0141931. eCollection 2015.

13.

Glomerular filtration rate measured by (99m) Tc-DTPA renal dynamic imaging is significantly lower than that estimated by the CKD-EPI equation in horseshoe kidney patients.

Qi Y, Hu P, Xie Y, Wei K, Jin M, Ma G, Li Q, Xu B, Chen X.

Nephrology (Carlton). 2016 Jun;21(6):499-505. doi: 10.1111/nep.12663.

14.

A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.

Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, He J.

Kidney Int. 2015 Nov;88(5):950-7. doi: 10.1038/ki.2015.230. Epub 2015 Jul 29. Review.

15.

Aging and low-grade inflammation reduce renal function in middle-aged and older adults in Japan and the USA.

Costello-White R, Ryff CD, Coe CL.

Age (Dordr). 2015 Aug;37(4):9808. doi: 10.1007/s11357-015-9808-7. Epub 2015 Jul 19.

16.

Association of hemoglobin A1c and glycated albumin with carotid atherosclerosis in community-dwelling Japanese subjects: the Hisayama Study.

Mukai N, Ninomiya T, Hata J, Hirakawa Y, Ikeda F, Fukuhara M, Hotta T, Koga M, Nakamura U, Kang D, Kitazono T, Kiyohara Y.

Cardiovasc Diabetol. 2015 Jun 24;14:84. doi: 10.1186/s12933-015-0247-7.

17.

Chronic kidney disease screening methods and its implication for Malaysia: an in depth review.

Almualm Y, Zaman Huri H.

Glob J Health Sci. 2015 Jan 1;7(4):96-109. doi: 10.5539/gjhs.v7n4p96. Review.

18.

Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study.

Matsui M, Uemura S, Takeda Y, Samejima K, Matsumoto T, Hasegawa A, Tsushima H, Hoshino E, Ueda T, Morimoto K, Okamoto K, Okada S, Onoue K, Okayama S, Kawata H, Kawakami R, Maruyama N, Akai Y, Iwano M, Shiiki H, Saito Y; NARA-CKD Investigators.

J Am Soc Nephrol. 2015 Nov;26(11):2871-81. doi: 10.1681/ASN.2014080772. Epub 2015 Mar 18.

19.

Biomarkers in chronic kidney disease, from kidney function to kidney damage.

Lopez-Giacoman S, Madero M.

World J Nephrol. 2015 Feb 6;4(1):57-73. doi: 10.5527/wjn.v4.i1.57. Review.

20.

Chapter 7: Blood pressure management in elderly persons with CKD ND.

[No authors listed]

Kidney Int Suppl (2011). 2012 Dec;2(5):377-381. No abstract available.

Supplemental Content

Support Center